These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15680225)

  • 1. Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins.
    Panzenböck U; Stocker R
    Biochim Biophys Acta; 2005 Jan; 1703(2):171-81. PubMed ID: 15680225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.
    Pankhurst G; Wang XL; Wilcken DE; Baernthaler G; Panzenböck U; Raftery M; Stocker R
    J Lipid Res; 2003 Feb; 44(2):349-55. PubMed ID: 12576517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
    Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
    J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL.
    Wang XS; Shao B; Oda MN; Heinecke JW; Mahler S; Stocker R
    J Lipid Res; 2009 Mar; 50(3):586-594. PubMed ID: 18832772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.
    Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R
    J Biol Chem; 1998 Mar; 273(11):6088-95. PubMed ID: 9497326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased methionine sulfoxide content of apoA-I in type 1 diabetes.
    Brock JW; Jenkins AJ; Lyons TJ; Klein RL; Yim E; Lopes-Virella M; Carter RE; ; Thorpe SR; Baynes JW
    J Lipid Res; 2008 Apr; 49(4):847-55. PubMed ID: 18202432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients.
    Seraglia R; Sartore G; Marin R; Burlina S; Manzato E; Ragazzi E; Traldi P; Lapolla A
    J Mass Spectrom; 2013 Jan; 48(1):105-10. PubMed ID: 23303753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction.
    Sartore G; Seraglia R; Burlina S; Bolis A; Marin R; Manzato E; Ragazzi E; Traldi P; Lapolla A
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):418-25. PubMed ID: 25636381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modification of lipoproteins.
    Arai H
    Subcell Biochem; 2014; 77():103-14. PubMed ID: 24374922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of specifically oxidized apolipoproteins in oxidized HDL.
    Wang XS; Stocker R
    Methods Mol Biol; 2008; 477():49-63. PubMed ID: 19082938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation, intestine, and paraoxonase-1.
    Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
    Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein.
    Zhang X; Wang J; Chen B
    Biochem Biophys Res Commun; 2010 Oct; 401(3):473-9. PubMed ID: 20869952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.
    Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G
    FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.
    Navab M; Hama SY; Cooke CJ; Anantharamaiah GM; Chaddha M; Jin L; Subbanagounder G; Faull KF; Reddy ST; Miller NE; Fogelman AM
    J Lipid Res; 2000 Sep; 41(9):1481-94. PubMed ID: 10974056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule.
    Witkowski A; Carta S; Lu R; Yokoyama S; Rubartelli A; Cavigiolio G
    J Biol Chem; 2019 Mar; 294(10):3634-3646. PubMed ID: 30635405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
    Verhoye E; Langlois MR;
    Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.